|
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).
Alembic Pharmaceuticals Ltd.
Main Activities: Chemical Manufacturing - Health and Personal Care Stores
 |
Please check the full coverage of information what EMIS can offer you. | SEE SAMPLE |
Company Information |
|
Full name Alembic Pharmaceuticals Ltd. Legal Address Alembic Road, , ; Vadodara; Gujarat; 390003 |
Status: Listed Legal Form: Public Limited Company Operational Status: Operational Financial Auditors: KS Aiyar & Co (2011) Tel: 2280550/ 2280880/ |
|
Company Description |
|
Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation |
||
|
||
Company Analysis |
| According to the Consolidated - Audited financial statement for the Year of 2012, total net operating revenues increased with 22.02%, from INR 1,202.13 tens of millions to INR 1,466.83 tens of millions. Operating result increased from INR 160.27 tens of millions to INR 219.42 tens of millions which means 36.91% change. The results of the period increased 52.39% reaching INR 130.13 tens of millions at the end of the period against INR 85.39 tens of millions last year. Return on equity (Net income/Total equity) went from 28.92% to 33.41%, the Return On Asset (Net income / Total Asset) went from 13.55% to 12.37% and the Net Profit Margin (Net Income/Net Sales) went from 7.10% to 8.87% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 270.04% compared to 213.36% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.54 to 1.75 when compared to the previous year. |
Key Executives |
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
|
|||||
Companies with Similar Main Activities |
FULL COMPANY PROFILE
|
|
2013 Y (cons) |
2013 Q3C (cons) |
|
 | ||
| Non-Audited | Non-Audited | |
| ||
| Dion Global Solutions - AsianCERC | Dion Global Solutions - AsianCERC | |
| ||
| Unit | Tens of Millions) | Tens of Millions |
| ||
Balance Sheet
| ||
Shareholders Equity |
502 |
37 |
| ||
| * All the accounts are in INR. | ||
Income Statement
| ||
Total Operating Revenue |
1,520 |
1,142 |
| ||
Net Profit (Loss) |
165 |
121 |
| ||
| * All the accounts are in INR. | ||
Ratios
| Profitability Ratios | ||
| ||
Return on Equity (ROE) |
438.33% |
322.55% |
| ||
Annualised Return on Equity (ROE) |
438.33% |
430.07% |
| ||
Return on Sales (ROS) |
100.2% |
100.2% |
| ||
 |